Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography
Authors:
- 27 June 2003
- journal article
- clinical trial
- Published by Springer Nature in European Radiology
- Vol. 13 (7) , 1620-1627
Abstract
The aim of this study was to test the safety and efficacy of NC100150 injection for steady-state contrast-enhanced peripheral MR angiography in a multicentre phase-II trial. Thirty-three patients underwent steady-state NC100150 enhanced MR angiography (5 mg Fe/kg body weight) of the aortoiliac and femoropopliteal arteries. Safety assessment consisted of pre- and post-injection (2, 24 and 72 h) monitoring of vital signs, physical examination as well as laboratory and electrocardiographic parameters. To determine sensitivity and specificity for detection of haemodynamically significant stenoses (HSS; >50% reduction of luminal diameter) MR angiograms were compared with intra-arterial digital subtraction angiography (IA DSA), which was considered the standard of reference. In 33 patients a mean of 12.8 ml NC100150 was injected. Eleven patients reported 13 mild and 2 moderate adverse events. Five mild and one moderate adverse event were considered due to NC100150 injection. There were no significant changes in vital signs, laboratory or electrocardiographic parameters. Sensitivity and specificity (in percent) for detection of HSS were 87 and 64, 56 and 76, and 75 and 84, for iliac, femoral and popliteal arteries, respectively. NC100150 high-resolution steady-state MR angiography can be performed safely and is feasible for the detection of peripheral arterial HSS, but is as yet not a clinically useful alternative to conventional gadolinium-enhanced MR angiography.Keywords
This publication has 18 references indexed in Scilit:
- Segmentation with gray‐scale connectedness can separate arteries and veins in MRAJournal of Magnetic Resonance Imaging, 2002
- Peripheral Arterial Disease: Meta-analysis of the Diagnostic Performance of MR AngiographyRadiology, 2000
- Equilibrium-Phase MR Angiography of the Aortoiliac and Renal Arteries Using a Blood Pool Contrast AgentAmerican Journal of Roentgenology, 2000
- NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiographyJournal of Magnetic Resonance Imaging, 2000
- Pelvic and Lower Extremity Arterial ImagingAmerican Journal of Roentgenology, 2000
- Prostate Cancer: Prediction of Extracapsular Extension with Endorectal MR Imaging and Three-dimensional Proton MR Spectroscopic ImagingRadiology, 1999
- First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injectionJournal of Magnetic Resonance Imaging, 1999
- Safety of magnetic resonance imaging contrast agentsJournal of Magnetic Resonance Imaging, 1999
- Blood pool contrast agents for cardiovascular MR imagingJournal of Magnetic Resonance Imaging, 1999
- Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography.Radiology, 1998